|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
65.74(B) |
Last
Volume: |
1,691,719 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bodner Charles R |
SVP Corp Fin Chief Acct Office |
|
2019-09-06 |
4 |
D |
$260.08 |
$423,670 |
D/D |
(1,629) |
3,551 |
|
- |
|
Bodner Charles R |
SVP Corp Fin Chief Acct Office |
|
2019-09-06 |
4 |
OE |
$134.73 |
$423,456 |
D/D |
3,143 |
5,180 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2019-09-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
59 |
12,549 |
|
- |
|
Conroy Alexandre |
EVP of Integrated Supply Chain |
|
2019-08-30 |
4 |
S |
$256.72 |
$11,809 |
D/D |
(46) |
16,489 |
|
- |
|
Conroy Alexandre |
EVP of Integrated Supply Chain |
|
2019-08-29 |
4 |
S |
$255.06 |
$2,506,985 |
D/D |
(9,829) |
16,535 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-08-23 |
4 |
GA |
$0.00 |
$0 |
D/D |
6,443 |
221,088 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-09 |
4 |
S |
$253.31 |
$6,048,789 |
D/D |
(23,879) |
17,193 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-09 |
4 |
D |
$253.31 |
$2,555,138 |
D/D |
(10,087) |
33,072 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-09 |
4 |
OE |
$72.12 |
$2,554,731 |
D/D |
33,966 |
39,902 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-08-09 |
4 |
S |
$253.78 |
$32,230 |
D/D |
(127) |
15,930 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-08-08 |
4 |
S |
$246.53 |
$98,620 |
D/D |
(400) |
16,057 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-08-08 |
4 |
D |
$246.56 |
$644,754 |
D/D |
(2,615) |
16,457 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-08-08 |
4 |
OE |
$224.94 |
$644,453 |
D/D |
2,865 |
19,072 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2019-08-08 |
4 |
S |
$249.88 |
$429,044 |
D/D |
(1,717) |
6,247 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2019-08-08 |
4 |
D |
$249.88 |
$186,410 |
D/D |
(746) |
7,964 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2019-08-08 |
4 |
OE |
$75.63 |
$186,277 |
D/D |
2,463 |
8,710 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-08 |
4 |
S |
$252.01 |
$486,127 |
D/D |
(1,929) |
17,193 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-08 |
4 |
D |
$252.01 |
$212,696 |
D/D |
(844) |
19,122 |
|
- |
|
Lim James C |
Executive Vice President |
|
2019-08-08 |
4 |
OE |
$76.64 |
$212,523 |
D/D |
2,773 |
19,966 |
|
- |
|
Fraser-Liggett Claire |
Director |
|
2019-08-07 |
4 |
S |
$243.26 |
$347,619 |
D/D |
(1,429) |
21,544 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-06-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,026 |
214,645 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2019-06-12 |
4 |
S |
$236.94 |
$687,837 |
D/D |
(2,903) |
9,408 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-10 |
4 |
S |
$241.03 |
$46,037 |
D/D |
(191) |
16,207 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-10 |
4 |
D |
$241.03 |
$644,514 |
D/D |
(2,674) |
16,398 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-06-10 |
4 |
OE |
$224.94 |
$644,453 |
D/D |
2,865 |
19,072 |
|
- |
|
863 Records found
|
|
Page 15 of 35 |
|
|